CRIS Current Research Information System

PINNA, ANTONIO DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.271
EU - Europa 16.858
AS - Asia 9.781
AF - Africa 1.241
SA - Sud America 64
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 11
Totale 56.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.196
GB - Regno Unito 5.461
CN - Cina 3.350
VN - Vietnam 2.633
SG - Singapore 2.330
SE - Svezia 2.256
DE - Germania 2.253
IT - Italia 2.018
UA - Ucraina 1.137
IN - India 1.037
IE - Irlanda 824
FR - Francia 734
RU - Federazione Russa 713
ZA - Sudafrica 463
EE - Estonia 427
TG - Togo 341
CH - Svizzera 291
CI - Costa d'Avorio 238
BG - Bulgaria 213
JO - Giordania 161
FI - Finlandia 126
NG - Nigeria 119
BE - Belgio 96
CA - Canada 68
SC - Seychelles 67
IR - Iran 58
JP - Giappone 58
GR - Grecia 53
NL - Olanda 42
AT - Austria 38
ES - Italia 37
BR - Brasile 36
RO - Romania 33
PL - Polonia 24
TR - Turchia 24
HR - Croazia 22
CL - Cile 20
LB - Libano 20
HK - Hong Kong 18
AU - Australia 16
UZ - Uzbekistan 15
ID - Indonesia 12
CZ - Repubblica Ceca 11
MY - Malesia 11
DK - Danimarca 8
NO - Norvegia 8
PT - Portogallo 8
EU - Europa 7
KR - Corea 7
PK - Pakistan 7
IL - Israele 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PE - Perù 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
BD - Bangladesh 3
KH - Cambogia 3
LK - Sri Lanka 3
MD - Moldavia 3
SA - Arabia Saudita 3
TH - Thailandia 3
AL - Albania 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
MM - Myanmar 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
UG - Uganda 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
Totale 56.247
Salva come PNG Salva come JPEG
Città #
Southend 5.014
Fairfield 3.993
Chandler 2.306
Ashburn 2.199
Singapore 2.073
Woodbridge 1.988
Dong Ket 1.785
Houston 1.728
Wilmington 1.724
Seattle 1.591
Cambridge 1.427
Princeton 1.203
Santa Clara 1.200
Ann Arbor 1.053
Dublin 773
Jacksonville 658
Boardman 653
Nanjing 550
Westminster 529
Padova 480
Bologna 377
Berlin 364
Lomé 341
Saint Petersburg 268
Bern 256
Jinan 253
Shenyang 239
Abidjan 238
San Diego 231
Sofia 211
Beijing 180
New York 175
Hebei 165
Dearborn 164
Nanchang 163
Amman 161
Changsha 159
Turin 147
Mülheim 139
Florence 135
Medford 133
Helsinki 125
Abeokuta 118
Tianjin 113
Jiaxing 112
Menlo Park 112
Milan 104
Bremen 100
Falls Church 93
Norwalk 93
Brussels 92
Guangzhou 89
Redmond 86
Zhengzhou 82
Redwood City 81
Olalla 78
Hangzhou 74
Des Moines 70
Los Angeles 69
Mahé 63
Ningbo 62
Haikou 60
Lanzhou 56
Shanghai 52
Tokyo 51
Fuzhou 49
Taizhou 49
Verona 46
Toronto 43
Bühl 39
Taiyuan 39
Kunming 35
Mountain View 35
Hefei 31
London 31
Pune 31
Phoenix 29
San Venanzo 29
Vienna 29
Monmouth Junction 27
Paris 26
Rome 26
Leawood 25
Wuhan 25
Hyderabad 23
São Paulo 21
Chengdu 19
Costa Mesa 19
Frankfurt Am Main 19
Frankfurt am Main 19
San Francisco 18
Xi'an 18
Zanjan 18
Ardabil 17
Washington 17
Amsterdam 16
Chicago 16
Fremont 16
Castelnuovo Rangone 15
Harbin 15
Totale 40.391
Salva come PNG Salva come JPEG
Nome #
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 339
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 237
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 213
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 213
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 207
A comprehensive analysis on expected years of life lost due to pancreatic cancer 202
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 202
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 192
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 189
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 189
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 188
A new liver transplant priority for patients with hepatocellular carcinoma. 186
Burnout and psychological distress between surgical and non-surgical residents 185
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 180
Combined liver-kidney transplantation: the experience of the University of Bologna and the case of preoperative positive cross-match. 179
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 179
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 176
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 174
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 171
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 171
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 170
Combined liver–dual kidney transplant: Role in expanded donors 170
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 166
Acute cellular rejection monitoring after interstinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings. 165
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 163
Bacterial translocation in adult small bowel transplantation 163
A simplified technique for the en-bloc procurement of abdominal organs that is suitable for pancreas and small bowel transplantation. 163
Abdominal wall transplantation with microsurgical technique 162
Long-term endoscopic follow-up in small bowel transplant recipients: single-center series. 161
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 161
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 161
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 160
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 160
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 157
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 157
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 156
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 156
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 156
Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy 155
Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer. 155
Combined liver-kidney transplantation-s. Orsola experience: nephrological aspects. 154
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 153
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 153
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 153
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 153
Analysis of 80 dual-kidney transplantations: a multicenter experience. 153
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 152
ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy. 152
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 151
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 151
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 151
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 150
Combined heart and liver transplantation for familial amyloidotic polyneuropathy. 150
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 150
A prospective multi-center randomized clinical study to compare the efficacy of ertapenem 3 days versus ampicillin-sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection 150
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 150
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 149
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 149
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 148
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 148
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 148
Coping strategies in intestinal transplantation 147
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 147
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 146
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 146
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 146
A Multicentric Study on Double Kidney Transplantation 145
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 145
COMBINED KIDNEY LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE 144
T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam 144
Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation 144
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 144
Analysis of cardiovascular, acid-base status, electrolyte and coagulation changes during small bowel transplantation 143
Combined liver transplants: main characteristics from the standpoint of anesthesia and support in intensive care 142
Multimodal Surgical Approach for Adult Patients With Chronic Intestinal Pseudo-Obstruction: Clinical and Psychosocial Long-term Outcomes 142
null 142
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 141
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 141
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 140
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 140
Age and equity in liver transplantation: An organ allocation model. 140
Psychological and Physical Health in Patients with CIPO: Transplant and Non-Transplant Surgery 140
Impact of preoperative infection on outcome after liver transplantation 140
Combined heart-liver transplantation: A single-center experience 140
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 139
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 139
Efficacy of MELD score in predicting survival after liver retransplantation. 138
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 138
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 138
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 138
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 138
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 137
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 136
Iliac Approach for Vascularization of an Intestinal Graft at Retransplantation. 135
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 135
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 135
null 135
Using Elderly Donors in Liver Transplantation. 134
Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy 134
Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. 134
Totale 15.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.306
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.256 0 0 0 0 0 1.669 2.009 2.039 2.146 1.002 563 828
2020/20218.083 1.682 595 258 319 142 341 114 394 632 371 333 2.902
2021/20229.997 1.003 403 591 794 955 535 236 630 356 507 2.252 1.735
2022/202310.191 1.139 1.611 579 1.339 621 705 269 551 1.771 241 861 504
2023/20242.451 202 479 121 264 170 510 117 174 83 171 72 88
2024/20255.783 426 1.858 826 767 1.897 9 0 0 0 0 0 0
Totale 57.402